The Chairman of the Cardiovascular Medicine at the Cleveland Clinic, in Cleveland Ohio has reported that a drug known as Rosiglitazone (Adavandia(TM) raises a patents’ chances of a heart attack and death by 43%. The drug also has the same risk by 64% when compared to other drugs such as placebos and other anti-diabetic therapies.
With 65% of diabetic deaths being caused by heart attacks, these findings are sending up the red flags. 
Cleveland Clinic was founded in 1921, and continues to be one of the top hospitals in the United States. Therefore their findings are respected around the world.
If you …read more